Effects of Musculoskeletal Rehabilitation Courses on Work Ability
Launched by SOCIAL INSURANCE INSTITUTION, FINLAND · Dec 19, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Groups 1 ja 2:
- • diagnosed musculoskeletal disorder
- • 18 years or older
- • in employment, returning to work, studying, or receives rehabilitation subsidy
- * participating in either of the following:
- • Kela's face-to-face musculoskeletal rehabilitation (A)
- • Kela's musculoskeletal telerehabilitation (B)
- • willingness to participate in the study
- Group 3 (Controls):
- • diagnosed musculoskeletal disorder
- • 18 years or older
- • in employment, returning to work, studying, or receives rehabilitation subsidy
- • musculoskeletal symptoms have lasted at least 3 months and the person has participated in physiotherapy or self-rehabilitation without satisfactory results
- • willingness to participate in the study
- Exclusion Criteria:
- Group 3 (Controls):
- • Current rehabilitation needs are related to post-treatment care or post-discharge rehabilitation.
- • acute or untreated substance use disorder
- • participating in or apply for Kela's musculoskeletal rehabilitation services (A or B) during the next few months
About Social Insurance Institution, Finland
The Social Insurance Institution of Finland (Kela) is a government agency responsible for providing social security services and support to Finnish residents. As a clinical trial sponsor, Kela plays a pivotal role in advancing public health by funding and facilitating research that evaluates the effectiveness and safety of medical interventions. By collaborating with healthcare professionals, researchers, and institutions, Kela aims to improve healthcare outcomes and ensure equitable access to innovative treatments across the population. The institution is committed to upholding the highest ethical standards and promoting transparency in clinical research, thereby contributing to the overall enhancement of the Finnish healthcare system.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Helsinki, , Finland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported